Omnicell [OMCL] vs Teladoc Health [TDOC] Detailed Stock Comparison
Omnicell
NASDAQ
Loading...
Teladoc Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Omnicell wins in 9 metrics, Teladoc Health wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Omnicell | Teladoc Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 61.90 | -1.50 | Teladoc Health |
| Price-to-Book Ratio | 1.14 | 1.12 | Teladoc Health |
| Debt-to-Equity Ratio | 30.42 | 72.78 | Omnicell |
| PEG Ratio | 1.24 | 0.02 | Teladoc Health |
| EV/EBITDA | 19.00 | 103.14 | Omnicell |
| Profit Margin (TTM) | 2.01% | -8.16% | Omnicell |
| Operating Margin (TTM) | 2.80% | -7.29% | Omnicell |
| EBITDA Margin (TTM) | 2.80% | N/A | N/A |
| Return on Equity | 1.87% | -14.18% | Omnicell |
| Return on Assets (TTM) | 0.49% | -3.57% | Omnicell |
| Free Cash Flow (TTM) | $134.93M | $169.63M | Teladoc Health |
| 1-Year Return | -28.39% | -6.85% | Teladoc Health |
| Price-to-Sales Ratio (TTM) | 1.24 | 0.63 | Teladoc Health |
| Enterprise Value | $1.41B | $1.95B | Teladoc Health |
| EV/Revenue Ratio | 1.22 | 0.77 | Teladoc Health |
| Gross Profit Margin (TTM) | 43.94% | 69.85% | Teladoc Health |
| Revenue per Share (TTM) | $25 | $15 | Omnicell |
| Earnings per Share (Diluted) | $0.50 | $-1.15 | Omnicell |
| Beta (Stock Volatility) | 0.88 | 1.91 | Omnicell |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Omnicell vs Teladoc Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Omnicell | -1.39% | 0.59% | -5.60% | 5.53% | -3.42% | -31.14% |
| Teladoc Health | -4.88% | 4.51% | 9.31% | 6.20% | 18.53% | -9.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Omnicell | -28.39% | -58.34% | -62.99% | 0.36% | 126.07% | 225.72% |
| Teladoc Health | -6.85% | -63.00% | -96.13% | -52.39% | -69.39% | -69.39% |
News Based Sentiment: Omnicell vs Teladoc Health
Omnicell
News based Sentiment: MIXED
October brought a blend of positive and negative developments for Omnicell, including insider buying, a 'Buy' rating, but also recent price declines and a significant year-over-year loss in market capitalization. The upcoming Q3 earnings report on October 29th is a key catalyst that will shape the investment narrative.
Teladoc Health
News based Sentiment: MIXED
October was a month of conflicting signals for Teladoc, with continued financial challenges offset by a surprising stock surge and strategic initiatives. The regulatory environment remains a key risk, creating a mixed outlook for investors. The combination of positive market reaction and underlying financial concerns makes this a significant month for the company.
Performance & Financial Health Analysis: Omnicell vs Teladoc Health
| Metric | OMCL | TDOC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.46B | $1.59B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 350,293 | 8,888,160 |
| 90 Day Avg. Volume | 488,778 | 5,961,557 |
| Last Close | $30.52 | $8.57 |
| 52 Week Range | $22.66 - $55.75 | $6.35 - $15.21 |
| % from 52W High | -45.26% | -43.66% |
| All-Time High | $187.29 (Nov 22, 2021) | $308.00 (Feb 15, 2021) |
| % from All-Time High | -83.70% | -97.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | -0.02% |
| Quarterly Earnings Growth | 0.51% | -0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.08% |
| Operating Margin (TTM) | 0.03% | -0.07% |
| Return on Equity (TTM) | 0.02% | -0.14% |
| Debt to Equity (MRQ) | 30.42 | 72.78 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.22 | $8.05 |
| Cash per Share (MRQ) | $8.69 | $3.85 |
| Operating Cash Flow (TTM) | $147.75M | $303.43M |
| Levered Free Cash Flow (TTM) | $85.81M | $209.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Omnicell vs Teladoc Health
| Metric | OMCL | TDOC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 61.90 | -1.50 |
| Forward P/E | 17.19 | -10.12 |
| PEG Ratio | 1.24 | 0.02 |
| Price to Sales (TTM) | 1.24 | 0.63 |
| Price to Book (MRQ) | 1.14 | 1.12 |
| Market Capitalization | ||
| Market Capitalization | $1.46B | $1.59B |
| Enterprise Value | $1.41B | $1.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.22 | 0.77 |
| Enterprise to EBITDA | 19.00 | 103.14 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 1.91 |
| Book Value per Share (MRQ) | $27.22 | $8.05 |
Financial Statements Comparison: Omnicell vs Teladoc Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OMCL | TDOC |
|---|---|---|
| Revenue/Sales | $290.56M | $629.37M |
| Cost of Goods Sold | $162.88M | $196.83M |
| Gross Profit | $127.68M | $432.54M |
| Research & Development | $21.57M | $69.96M |
| Operating Income (EBIT) | $8.12M | $-54.94M |
| EBITDA | $29.77M | $50.34M |
| Pre-Tax Income | $10.45M | $-111.27M |
| Income Tax | $4.81M | $-18.26M |
| Net Income (Profit) | $5.64M | $-93.01M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OMCL | TDOC |
|---|---|---|
| Cash & Equivalents | $386.83M | $679.62M |
| Total Current Assets | $839.67M | $1.07B |
| Total Current Liabilities | $607.53M | $401.77M |
| Long-Term Debt | $199.72M | $1.03B |
| Total Shareholders Equity | $1.26B | $1.42B |
| Retained Earnings | $375.87M | $-16.36B |
| Property, Plant & Equipment | $130.63M | $27.67M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OMCL | TDOC |
|---|---|---|
| Operating Cash Flow | $28.34M | $89.56M |
| Capital Expenditures | $-11.17M | N/A |
| Free Cash Flow | $10.19M | $31.63M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | OMCL | TDOC |
|---|---|---|
| Shares Short | 1.97M | 23.82M |
| Short Ratio | 3.80 | 5.40 |
| Short % of Float | 0.06% | 0.15% |
| Average Daily Volume (10 Day) | 350,293 | 8,888,160 |
| Average Daily Volume (90 Day) | 488,778 | 5,961,557 |
| Shares Outstanding | 46.38M | 173.41M |
| Float Shares | 44.82M | 174.74M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.05% | 0.74% |
Dividend Analysis & Yield Comparison: Omnicell vs Teladoc Health
| Metric | OMCL | TDOC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |